S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AVTX Avalo Therapeutics Inc

7.76

0.43 (5.87%)

08 Mar 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Avalo Therapeutics Charts.

Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Avalo Therapeutics Charts.

Avalo Therapeutics Inc News

Avalo Therapeutics to Participate in Upcoming Investor Conferences
Monday 24 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
Wednesday 5 February 2025 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Saturday 4 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 2 January 2025 (2 months ago) • Edgar (US Regulatory)

Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
Thursday 2 January 2025 (2 months ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 1 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 5 December 2024 (3 months ago) • Edgar (US Regulatory)

More Avalo Therapeutics Inc News Articles

Cibox Interactive

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions